STAT3 and cancer: Although abundant evidence suggests that STAT3 is an ideal target for cancer therapy, to date, effective therapeutic interventions to inhibit STAT3 and generate a potent antitumor effect clinically remain to be explored and developed (Yu et al., 2014).